[Molecular pathogenesis and development of disease-modifying drugs for Alzheimer's disease].
Year: 2013
Type: article
Source: PubMed
Author: Masatoshi Takeda
Institution: The University of Osaka
Language: Japanese
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, disease-modifying drugs, molecular pathogenesis, cholinesterase inhibitors, NMDA receptor antagonists, donepezil, galantamine, rivastigmine, memantine, gamma-secretase inhibitors, γ-secretase modulators, BACE1 inhibitors, immunotherapy, clinical trial design, mild cognitive impairment, preclinical Alzheimer's disease, conversion to dementia
Open Access status: closed
OpenAlex ID: W2341133222
